MENU

NWBO Stock Northwest Biotherapeutics (NWBO, $0.26) Stochastic Oscillator left the oversold zone on June 24, 2025

A.I.dvisor
at Tickeron.com
Loading...
NWBO - Northwest Biotherapeutics, Inc.
Stochastic signal
Bullish Trend
Odds of UP Trend
Tickeron
Stochastic signal
Price: $0.2584
Daily change: +$0.0004 (+0.16%)
Daily volume: 941.9K
Capitalization: $371.5M
Industry: Biotechnology
This is a signal that NWBO's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. A.I.dvisor identified 71 similar cases where NWBO's stochastic oscillator exited the oversold zone, and of them led to successful outcomes. Odds of Success:

Momentum Indicator for NWBO turns negative, indicating new downward trend

NWBO saw its Momentum Indicator move below the 0 level on June 23, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned negative. In of the 90 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NWBO turned negative on June 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

NWBO moved below its 50-day moving average on June 16, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NWBO crossed bearishly below the 50-day moving average on June 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NWBO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NWBO entered a downward trend on June 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 50-day moving average for NWBO moved above the 200-day moving average on June 18, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NWBO advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

NWBO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.515). P/E Ratio (0.000) is within average values for comparable stocks, (59.269). NWBO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (222.222) is also within normal values, averaging (253.659).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NWBO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NWBO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NWBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of immunotherapy products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4800 Montgomery Lane
Phone
+1 240 497-9024
Employees
22
Web
https://www.nwbio.com